JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reynolds, R. D.
Right arrow Articles by Reutter, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, R. D.
Right arrow Articles by Reutter, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of Induction of Rat Liver Tyrosine Aminotransferase by d-Galactosamine

ROLE OF URIDINE TRIPHOSPHATE

Robert D. Reynolds 1 and Werner Reutter 1

From the 1 From the Biochemisches Institut, Universität Freiburg, 78 Freiburg im Breisgau, Germany

1. An injection of d-galactosamine at the same time as an injection of dexamethasone inhibits the increase of rat liver tyrosine aminotransferase activity normally observed following injection of dexamethasone alone. The galactosamine-mediated inhibition is dose dependent: a 50% inhibition of the increase of enzyme activity is observed at 10 mg of galactosamine·HCl per 100 g of body weight, and a total inhibition is observed at 15 mg per 100 g of body weight. Following a single injection of 37.5 mg of galactosamine·HCl per 100 g of body weight, the basal level of tyrosine aminotransferase activity does not change for at least 16 hours.

2. Induction of the enzyme by glucagon or dibutyryl cyclic AMP is only partially inhibited by a dose of 37.5 mg of galactosamine·HCl per 100 g of body weight.

3. The total inhibition of the dexamethasone-induced enzyme increase is specific for galactosamine. A high dose of d-glucose or d-galactose has no inhibitory effect, and a high dose of d-glucosamine or 2-deoxy-d-galactose has only a partially inhibitory effect.

4. The inhibition by galactosamine of the dexamethasone-induced enzyme increase can be prevented by simultaneous injection of uridine. Determination of the uridine phosphate levels following injection of different doses of galactosamine reveals a partial inhibition of the enzyme induction below 100 nmoles of UTP+UDP per g of liver and a total inhibition of enzyme induction below 40 to 50 nmoles of UTP+UDP per g of liver.

5. There is little or no relationship between levels of galactosamine metabolites in the liver and inhibition of enzyme induction.

6. Unlike actinomycin D, injection of galactosamine at various times after injection of dexamethasone does not result in a superinduction of tyrosine aminotransferase.

Submitted on September 25, 1972


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1973 by the American Society for Biochemistry and Molecular Biology.